Technology
GE Healthcare looks to the future of molecular imaging through improving cost, quality and access by helping clinicians deliver responsible care, both clinically and economically. This includes a focus on positron emission tomography (PET) treatment assessment, reinforced by a portfolio of quantitative imaging tools to help clinicians detect, diagnose and monitor disease earlier, and to evaluate cancer treatment efficacy more quickly.
October 20, 2011
Technology
October 20, 2011 – GE Healthcare’s CT and Advantage Workstation team at RSNA 2011 will showcase innovative new products and technologies that may enable physicians to diagnose more confidently while improving image clarity, reducing patient dose and enhancing workflow.
October 20, 2011News
October 19, 2011— W. L. Gore and Associates announced that the company purchased the assets and intellectual property of now defunct company NMT Medical Inc. The purchase included the data related to CLOSURE I, a prospective, multi-center, randomized controlled trial of patent foramen ovale (PFO) closure with the Starflex Device versus best medical therapy for the prevention of recurrent stroke and /or transient ischemic attack (TIA) in patients with cryptogenic stroke/TIA and PFO.
October 19, 2011Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
October 19, 2011 - A new study published in Circulation: Cardiovascular Interventions shows lesions with large lipid cores are associated with a 50 percent risk of heart attack in patients undergoing coronary stent implantation.
October 19, 2011
News
October 19, 2011 – A new study proves the importance of electrocardiographic (ECG) screenings to identify heart abnormalities in young adults, including both athletes and non-athletes. The study, published in the October edition of HeartRhythm, the official journal of the Heart Rhythm Society, demonstrates the success of a high-volume ECG screening program designed to identify potential life-threatening heart arrhythmias in high school students. Of the more than 32,000 students screened, ECG abnormalities that may be associated with the risk of sudden cardiac death (SCD) were identified in more than 800 students.
October 19, 2011
News
October 19, 2011 – Boston Scientific has completed enrollment in a clinical trial to evaluate its WallFlex Biliary RX fully covered stent for the treatment of benign bile duct strictures (narrowing or blockages). This multi-center, prospective study enrolled 187 patients at 13 centers in 11 countries worldwide. Lead investigators in the study are Professor Jacques Deviere, M.D., Ph.D., of Hospital Erasme in Brussels, and Professor Guido Costamagna, M.D., of Policlinico A. Gemelli in Rome.
October 19, 2011Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
At RSNA 2011, Siemens will showcase its two newest groundbreaking Imaging IT solutions, syngo.via and syngo.plaza, representing the next generation of advanced visualization and agile PACS technologies that deliver cutting-edge functionalities to the clinical routine.
October 19, 2011
Technology
October 18, 2011 — For the first time, Ziehm Imaging offers its Ziehm Vision R mobile C-arm with a powerful 20 kilowatt (kW) generator. The compact monoblock generator triples the performance of the predecessor model and can be used for unlimited fluoroscopy time in the operating room (OR), as it is water-cooled.
October 18, 2011
Technology
October 18, 2011 — Randox Laboratories announced the launch of a high sensitivity troponin T control. The new control allows clinical laboratories to more accurately monitor and assess the performance of their high sensitivity troponin T (hsTnT) assay.
October 18, 2011Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
October 18, 2011 — At more than 40 percent, the mortality rate due to cardiovascular disease (CVD) in China is amongst the highest in the world. Its population faces a catalog of CVD risk factor statistics that expose high levels of obesity, diabetes, cholesterol and blood pressure; the male population also displays a smoking habit that is proving difficult to address. To help reverse these trends, the European Society of Cardiology (ESC) delivered an educational program at the 22nd Great Wall International Congress of Cardiology.
October 18, 2011
News
October 18, 2011 — The U.S. Food and Drug Administration (FDA) issued a proposed rule and draft special controls guidance lowering the risk classification for external pacemaker pulse generators from Class III (high-risk) to Class II (moderate-risk).
October 18, 2011
News
October 18, 2011 — Abbott announced the investigational Absorb bioresorbable vascular scaffold (BVS) has been recognized as the winner of the Medical Devices category in the 2011 Wall Street Journal Technology Innovation Awards. Absorb is an implantable device that restores blood flow by opening a blocked artery and providing support to the vessel until the device dissolves.
October 18, 2011Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
October 18, 2011 — A U.S. Food and Drug Administration (FDA) committee will discuss and make recommendations to expand Medtronic’s indication for its cardiac resynchronization therapy defibrillator (CRT-D) in Class II heart failure patients. The committee will also review a pre-market approval (PMA) application for CardioMEMS’ Heart Failure Pressure Measurement System (HF system).
October 18, 2011
News
October 18, 2011 — Boston Scientific Corp. has begun a phased launch of its Promus Element everolimus-eluting platinum chromium coronary stent system in China. The launch campaign will be expanded within the country based upon receipt of subsequent provincial reimbursement approvals.
October 18, 2011
News
October 18, 2011 – New research published in the October issue of the Journal of Hospital Medicine shows hospitals accredited by The Joint Commission (JC) outperformed non-accredited hospitals on a number of nationally standardized quality measures. The measures included acute myocardial infarction (AMI), heart failure, and pneumonia. The research also shows the performance gap between JC accredited and non-accredited hospitals increased over the years of the study.
October 18, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now